Thomas Fitzgerald
Chief Executive Officer at TRANSCODE THERAPEUTICS, INC.
Net worth: 962 $ as of 31/03/2024
Profile
Thomas A.
Fitzgerald is currently the President, CEO, CFO, Director, and VP-Administration at TransCode Therapeutics, Inc. He previously worked as an MD in the Corporate Finance and Investment Banking Unit at Leerink Partners LLC.
Prior to that, he served as the Chief Financial Officer at Velico Medical, Inc. from 2006 to 2018.
Mr. Fitzgerald completed his undergraduate degree at Stanford University and holds an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/12/2023 | 1,408 ( 0.02% ) | 962 $ | 31/03/2024 |
Thomas Fitzgerald active positions
| Companies | Position | Start |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Chief Executive Officer | 13/01/2024 |
Former positions of Thomas Fitzgerald
| Companies | Position | End |
|---|---|---|
Velico Medical, Inc.
 Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA. | Director of Finance/CFO | 01/12/2018 |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | - |
Training of Thomas Fitzgerald
| Stanford University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
Velico Medical, Inc.
Velico Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA. | Electronic Technology |
- Stock Market
- Insiders
- Thomas Fitzgerald
